fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and.
yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital..
�we have waited a long time and we cannot possibly wait any longer,� karmenu vella, european commissioner for environment, told the guardian..
.
.
air pollution in the united kingdom has been illegally high since 2010, leading to the premature deaths of 23,500 people each year,.